Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system

Pharm Dev Technol. 2017 May;22(3):390-398. doi: 10.1080/10837450.2016.1213745. Epub 2016 Jul 28.

Abstract

In the present work, insulin-chitosan polyelectrolyte complexes associated to lecithin liposomes were investigated as a new carrier for oral delivery of insulin. The preparation was characterized in terms of particle size, zeta potential and encapsulation efficiency. Surface tension measurements revealed that insulin-chitosan polyelectrolyte complexes have some degree of hydrophobicity and should be added to lecithin liposomal dispersion and not the vice versa to prevent their adsorption on the surface. Stability of insulin was enhanced when it was associated to liposomes. Significant reduction of blood glucose levels was noticed after oral administration of liposomal preparation to streptozotocin diabetic rats compared to control. The hypoglycemic activity was more prolonged compared to subcutaneously administered insulin.

Keywords: Chitosan; insulin; lecithin; liposomes; nanovesicles.

MeSH terms

  • Administration, Oral
  • Animals
  • Chitosan / chemistry*
  • Diabetes Mellitus, Experimental / drug therapy
  • Drug Carriers / chemistry*
  • Drug Stability
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / therapeutic use
  • Insulin / administration & dosage*
  • Insulin / therapeutic use
  • Lecithins / chemistry*
  • Liposomes
  • Male
  • Nanoparticles / chemistry*
  • Rats, Wistar
  • Surface Properties

Substances

  • Drug Carriers
  • Hypoglycemic Agents
  • Insulin
  • Lecithins
  • Liposomes
  • Chitosan